338 related articles for article (PubMed ID: 32510618)
1. The aryl hydrocarbon receptor ligand ITE inhibits cell proliferation and migration and enhances sensitivity to drug-resistance in hepatocellular carcinoma.
Zhang X; He B; Chen E; Lu J; Wang J; Cao H; Li L
J Cell Physiol; 2021 Jan; 236(1):178-192. PubMed ID: 32510618
[TBL] [Abstract][Full Text] [Related]
2. ITE, an endogenous aryl hydrocarbon receptor ligand, suppresses endometrial cancer cell proliferation and migration.
Bian Y; Li Y; Shrestha G; Wen X; Cai B; Wang K; Wan X
Toxicology; 2019 Jun; 421():1-8. PubMed ID: 30953668
[TBL] [Abstract][Full Text] [Related]
3. An endogenous aryl hydrocarbon receptor ligand inhibits proliferation and migration of human ovarian cancer cells.
Wang K; Li Y; Jiang YZ; Dai CF; Patankar MS; Song JS; Zheng J
Cancer Lett; 2013 Oct; 340(1):63-71. PubMed ID: 23851185
[TBL] [Abstract][Full Text] [Related]
4. 1'H-Indole-3'-Carbonyl-Thiazole-4-Carboxylic Acid Methyl Ester Blocked Human Glioma Cell Invasion via Aryl Hydrocarbon Receptor's Regulation of Cytoskeletal Contraction.
Zhao L; Shu Q; Sun H; Ma Y; Kang D; Zhao Y; Lu J; Gong P; Yang F; Wan F
Biomed Res Int; 2020; 2020():2616930. PubMed ID: 33083460
[TBL] [Abstract][Full Text] [Related]
5. Activation of Aryl Hydrocarbon Receptor by ITE Improves Cardiac Function in Mice After Myocardial Infarction.
Seong E; Lee JH; Lim S; Park EH; Kim E; Kim CW; Lee E; Oh GC; Choo EH; Hwang BH; Kim CJ; Ihm SH; Youn HJ; Chung WS; Chang K
J Am Heart Assoc; 2021 Jul; 10(13):e020502. PubMed ID: 34157850
[TBL] [Abstract][Full Text] [Related]
6. Induction of a chloracne phenotype in an epidermal equivalent model by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on aryl hydrocarbon receptor activation and is not reproduced by aryl hydrocarbon receptor knock down.
Forrester AR; Elias MS; Woodward EL; Graham M; Williams FM; Reynolds NJ
J Dermatol Sci; 2014 Jan; 73(1):10-22. PubMed ID: 24161567
[TBL] [Abstract][Full Text] [Related]
7. Aryl Hydrocarbon Receptor Signaling Prevents Activation of Hepatic Stellate Cells and Liver Fibrogenesis in Mice.
Yan J; Tung HC; Li S; Niu Y; Garbacz WG; Lu P; Bi Y; Li Y; He J; Xu M; Ren S; Monga SP; Schwabe RF; Yang D; Xie W
Gastroenterology; 2019 Sep; 157(3):793-806.e14. PubMed ID: 31170413
[TBL] [Abstract][Full Text] [Related]
8. ITE inhibits growth of human pulmonary artery endothelial cells.
Pang LP; Li Y; Zou QY; Zhou C; Lei W; Zheng J; Huang SA
Exp Lung Res; 2017 Oct; 43(8):283-292. PubMed ID: 29140133
[TBL] [Abstract][Full Text] [Related]
9. A potential endogenous ligand for the aryl hydrocarbon receptor has potent agonist activity in vitro and in vivo.
Henry EC; Bemis JC; Henry O; Kende AS; Gasiewicz TA
Arch Biochem Biophys; 2006 Jun; 450(1):67-77. PubMed ID: 16545771
[TBL] [Abstract][Full Text] [Related]
10. Aryl Hydrocarbon Receptor Activity in Hepatocytes Sensitizes to Hyperacute Acetaminophen-Induced Hepatotoxicity in Mice.
Schuran FA; Lommetz C; Steudter A; Ghallab A; Wieschendorf B; Schwinge D; Zuehlke S; Reinders J; Heeren J; Lohse AW; Schramm C; Herkel J; Carambia A
Cell Mol Gastroenterol Hepatol; 2021; 11(2):371-388. PubMed ID: 32932016
[TBL] [Abstract][Full Text] [Related]
11. The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction.
He B; Dai L; Zhang X; Chen D; Wu J; Feng X; Zhang Y; Xie H; Zhou L; Wu J; Zheng S
Int J Biol Sci; 2018; 14(13):1845-1858. PubMed ID: 30443188
[TBL] [Abstract][Full Text] [Related]
12. The putative endogenous AHR ligand ITE reduces JAG1 and associated NOTCH1 signaling in triple negative breast cancer cells.
Piwarski SA; Thompson C; Chaudhry AR; Denvir J; Primerano DA; Fan J; Salisbury TB
Biochem Pharmacol; 2020 Apr; 174():113845. PubMed ID: 32032581
[TBL] [Abstract][Full Text] [Related]
13. Binding Mode and Structure-Activity Relationships of ITE as an Aryl Hydrocarbon Receptor (AhR) Agonist.
Dolciami D; Gargaro M; Cerra B; Scalisi G; Bagnoli L; Servillo G; Fazia MAD; Puccetti P; Quintana FJ; Fallarino F; Macchiarulo A
ChemMedChem; 2018 Feb; 13(3):270-279. PubMed ID: 29266750
[TBL] [Abstract][Full Text] [Related]
14. ITE Suppresses Angiogenic Responses in Human Artery and Vein Endothelial Cells: Differential Roles of AhR.
Li Y; Wang K; Zou QY; Jiang YZ; Zhou C; Zheng J
Reprod Toxicol; 2017 Dec; 74():181-188. PubMed ID: 28986273
[TBL] [Abstract][Full Text] [Related]
15. Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma.
Wang LT; Chiou SS; Chai CY; Hsi E; Wang SN; Huang SK; Hsu SH
Oncotarget; 2017 Jan; 8(5):7489-7501. PubMed ID: 27283490
[TBL] [Abstract][Full Text] [Related]
16. The aryl hydrocarbon receptor ligand ITE inhibits TGFβ1-induced human myofibroblast differentiation.
Lehmann GM; Xi X; Kulkarni AA; Olsen KC; Pollock SJ; Baglole CJ; Gupta S; Casey AE; Huxlin KR; Sime PJ; Feldon SE; Phipps RP
Am J Pathol; 2011 Apr; 178(4):1556-67. PubMed ID: 21406171
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Aryl Hydrocarbon Receptor with Microbial Metabolite Mimics Alleviates Experimental Colitis in Mice.
Grycová A; Joo H; Maier V; Illés P; Vyhlídalová B; Poulíková K; Sládeková L; Nádvorník P; Vrzal R; Zemánková L; Pečinková P; Poruba M; Zapletalová I; Večeřa R; Anzenbacher P; Ehrmann J; Ondra P; Jung JW; Mani S; Dvořák Z
J Med Chem; 2022 May; 65(9):6859-6868. PubMed ID: 35416668
[TBL] [Abstract][Full Text] [Related]
18. Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma through suppression of CD44s and the ERK1/2 pathway.
Hou H; Ge C; Sun H; Li H; Li J; Tian H
Cancer Sci; 2018 Apr; 109(4):1088-1100. PubMed ID: 29377347
[TBL] [Abstract][Full Text] [Related]
19. An endogenous aryl hydrocarbon receptor ligand, ITE, induces regulatory T cells and ameliorates experimental colitis.
Abron JD; Singh NP; Mishra MK; Price RL; Nagarkatti M; Nagarkatti PS; Singh UP
Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G220-G230. PubMed ID: 29672155
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
Wang ST; Ho HJ; Lin JT; Shieh JJ; Wu CY
Cell Death Dis; 2017 Feb; 8(2):e2626. PubMed ID: 28230855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
